Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir

CONCLUSION: NMV/r has significant DDIs with many common dermatological medications, which may require temporary discontinuation, dosage adjustment or substitution with other anti-COVID-19 agents such as molnupiravir.PMID:36592146 | DOI:10.47102/annals-acadmedsg.2022289
Source: Ann Acad Med Singapo... - Category: General Medicine Authors: Source Type: research